Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M(+) diffuse midline gliomas.
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M(+) diffuse midline gliomas.
复制标题
DOI:
10.1038/s41591-018-0006-x
复制
发表时间:
2018-05
期刊:
影响因子:
82.9
通讯作者:
Mackall CL
中科院分区:
文献类型:
--
作者:
Mount CW;Majzner RG;Sundaresh S;Arnold EP;Kadapakkam M;Haile S;Labanieh L;Hulleman E;Woo PJ;Rietberg SP;Vogel H;Monje M;Mackall CL
Diffuse intrinsic pontine glioma (DIPG) and other diffuse midline gliomas (DMGs) with mutated histone H3 K27M (H3-K27M), , , –are aggressive and universally fatal pediatric brain cancers. Chimeric antigen receptor (CAR)-expressing T cells have mediated impressive clinical activity in B cell malignancies, , –, and recent results suggest benefit in central nervous system malignancies, –. Here, we report that patient-derived H3-K27M-mutant glioma cell cultures exhibit uniform, high expression of the disialoganglioside GD2. Anti-GD2 CAR T cells incorporating a 4-1BBz costimulatory domain demonstrated robust antigen-dependent cytokine generation and killing of DMG cells in vitro. In five independent patient-derived H3-K27M+DMG orthotopic xenograft models, systemic administration of GD2-targeted CAR T cells cleared engrafted tumors except for a small number of residual GD2loglioma cells. To date, GD2-targeted CAR T cells have been well tolerated in clinical trials, –. Although GD2-targeted CAR T cell administration was tolerated in the majority of mice bearing orthotopic xenografts, peritumoral neuroinflammation during the acute phase of antitumor activity resulted in hydrocephalus that was lethal in a fraction of animals. Given the precarious neuroanatomical location of midline gliomas, careful monitoring and aggressive neurointensive care management will be required for human translation. With a cautious multidisciplinary clinical approach, GD2-targeted CAR T cell therapy for H3-K27M+diffuse gliomas of pons, thalamus and spinal cord could prove transformative for these lethal childhood cancers.
登录
查看更多内容
影响因子:
20.3
作者:
Gardner, Rebecca A.;Finney, Olivia;Jensen, Michael C.
通讯作者:
Jensen, Michael C.
影响因子:
28.2
作者:
Gust J;Hay KA;Hanafi LA;Li D;Myerson D;Gonzalez-Cuyar LF;Yeung C;Liles WC;Wurfel M;Lopez JA;Chen J;Chung D;Harju-Baker S;Özpolat T;Fink KR;Riddell SR;Maloney DG;Turtle CJ
通讯作者:
Turtle CJ
影响因子:
3.7
作者:
Jena B;Maiti S;Huls H;Singh H;Lee DA;Champlin RE;Cooper LJ
通讯作者:
Cooper LJ
影响因子:
3.2
作者:
Kramer K;Pandit-Taskar N;Humm JL;Zanzonico PB;Haque S;Dunkel IJ;Wolden SL;Donzelli M;Goldman DA;Lewis JS;Lyashchenko SK;Khakoo Y;Carrasquillo JA;Souweidane MM;Greenfield JP;Lyden D;De Braganca KD;Gilheeney SW;Larson SM;Cheung NV
通讯作者:
Cheung NV
影响因子:
82.9
作者:
Long, Adrienne H.;Haso, Waleed M.;Shern, Jack F.;Wanhainen, Kelsey M.;Murgai, Meera;Ingaramo, Maria;Smith, Jillian P.;Walker, Alec J.;Kohler, M. Eric;Venkateshwara, Vikas R.;Kaplan, Rosandra N.;Patterson, George H.;Fry, Terry J.;Orentas, Rimas J.;Mackall, Crystal L.
通讯作者:
Mackall, Crystal L.